Related by context. Frequent words. (Click for all words.) 83 Genasense R 75 Ganite 70 Amrubicin 68 Pirfenidone 68 relapsed multiple myeloma 68 HER2 positive metastatic breast 68 methylnaltrexone 68 castration resistant prostate cancer 67 Genasense 67 BAY #-# 67 Virulizin R 67 Voreloxin 67 anticancer therapy 67 Pivotal Phase III 67 pseudobulbar affect PBA 66 Nexavar ® 66 talactoferrin 66 biologic therapy 66 Gemcitabine 66 Irinotecan 66 TORISEL 66 Alemtuzumab 66 Allovectin 7 R 65 metastatic renal cell carcinoma 65 Hycamtin 65 axitinib 65 cutaneous T cell 65 relapsed refractory multiple myeloma 65 Jevtana 65 refractory multiple myeloma 65 humanized anti 65 MOZOBIL 65 FOLOTYN 65 Azedra 65 temsirolimus 65 Cloretazine R VNP#M 64 Bortezomib 64 INCB# [002] 64 EGFR expressing metastatic colorectal 64 Erlotinib 64 lymphoma CTCL 64 Perifosine 64 thymalfasin 64 Bevacizumab 64 Carfilzomib 64 HGS ETR1 64 SUTENT 64 Ofatumumab 64 CR# vcMMAE 64 Everolimus 64 registrational 64 Taxotere ® 64 TELCYTA 63 HRPC 63 alvimopan 63 aflibercept 63 TREANDA 63 Orphan Drug status 63 gastrointestinal stromal tumors 63 eniluracil 63 dacarbazine 63 AP# [003] 63 pralatrexate 63 diabetic neuropathic pain 63 hepatocellular carcinoma HCC 63 REPLAGAL 63 Belinostat 63 ROTATEQ 63 silodosin 63 ThermoDox ® 63 Advexin 63 TYKERB 63 deforolimus 63 OPAXIO 63 NOXAFIL 63 Cimzia R 63 BiTE antibody 63 malignant pleural mesothelioma 63 Laquinimod 63 hepatitis C HCV 63 Nimotuzumab 63 ridaforolimus 63 ZADAXIN 63 glufosfamide 63 romidepsin 63 PROMACTA 63 FavId 63 Fludara 62 Lenalidomide 62 carcinoid syndrome 62 Phase 2b clinical 62 IMGN# 62 Orphan Drug Status 62 IMC A# 62 Phase III Clinical Trial 62 pertuzumab 62 talabostat 62 CA4P 62 tanespimycin 62 Maraviroc 62 refractory Hodgkin lymphoma